Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH).
Jennifer PascoeAimee JacksonCharlotte GaskellClaire GauntJoyce ThompsonLucinda BillinghamNeil StevenPublished in: BMC cancer (2021)
ISRCTN registry: 39911673; 14-Apr-2011 https://doi.org/10.1186/ISRCTN39911673 .